Home LiteratureArticle Details
PMID: 2063479 Published · ppublish English Journal Article Review

Further subclassification of ATP receptors based on agonist studies.

Trends in pharmacological sciences ·Vol. 12 ·No. 4 ·1991-04-00 ·Pages 137-41

O'Connor SE, Dainty IA, Leff P

Abstract

Recent studies using agonist analogues of ATP and other nucleotides have generated some surprising observations which may have ramifications for the classification of P2 receptors, particularly for those responses currently attributed to P2Y receptor activation. 2-MethylthioATP (2-MeSATP), the conventional P2Y receptor agonist, does not interact with ATP in the expected fashion in various models of endothelial function, suggesting that it acts by a different mechanism. Furthermore, in certain cell types where responses to ATP are mediated by phospholipase C activation, 2-MeSATP has little or no activity. Interestingly, the pyrimidine uridine triphosphate (UTP) invariably shows similar potency to ATP in systems where 2-MeSATP is inactive. In this article Steve O'Connor and colleagues discuss these data and their significance, and propose that separate receptors may be responsible: one sensitive to 2-MeSATP and the other, a 'nucleotide' receptor, sensitive to UTP.

MeSH Terms
Animals Humans Receptors, Purinergic/drug effects
Chemicals
Receptors, Purinergic
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
O'Connor S E
Department of Pharmacology Research and Development Laboratories, Loughborough, UK.
Dainty I A
Leff P
Article Info
Journal
Trends in pharmacological sciences
Abbr.
Trends Pharmacol Sci
ISSN
0165-6147
Published
1991-04-00
Pages
137-41
Language
English
Region
England
NLM ID
7906158
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com